iSpecimen Inc. — Form 8-K
Filed August 7, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 22/100
What the filing says
iSpecimen Inc. filed exhibits for an equity offering including: (1) pre-funded warrant form exercisable at $0.0001 per share with immediate exercise rights; (2) placement agency agreement with E.F. Hutton Co. as exclusive agent at 4.0% cash fee + 1.0% expense allowance; (3) securities purchase agreement for direct issuance of common shares and/or pre-funded warrants to accredited investors. No specific dollar amounts or share counts disclosed in templates; pricing and investor identities to be determined. Registration Statement (File No. 333-297001) initially filed June 24, 2026, effective date redacted.
Why this rating
Template filing for routine equity offering. At $2.4M market cap, material raise would be significant, but specific terms unavailable. Standard financing mechanics.
See more from August 7, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.